United Kingdom Next Generation Sequencing Market to be dominated by Consumables till 2027
Continuous technological
advancements in next generation sequencing in developed countries like United
Kingdom is anticipated to cater to the growth of United Kingdom next generation
sequencing market in the forecast period, 2023-2027.
According to TechSci Research report, “United Kingdom Next Generation Sequencing
Market - By Region, Competition Forecast & Opportunities, 2027”, the United Kingdom next generation sequencing market is
expected to witness steady growth in 2023-2027. Next-generation
sequencing, also referred as high-throughput sequencing, represent the process
of determining the sequence of nucleotides in a section of the DNA. It includes
numerous procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing,
nanopore sequencing and single-molecule real-time (SMRT) sequencing. NGS is a
cost-effective solution that provide precise results with high accuracy and
speed. This allows the analysis of millions of DNA molecules simultaneously,
which facilitates research in personalized and genetic medicines, agriculture
and animal research, and clinical diagnostics. Moreover, the escalating demand
for early detection of cancer and infectious diseases drives the growth of the
NGS market. Also, the growing use of NGS technology in clinical diagnosis,
speed, cost, and accuracy of this sequencing method are supporting the growth
of the market. Additionally, the increasing efficiency in replacing the
traditional technologies (such as microarrays) and the expanding drug discovery
applications demanding NGS technology propels the market growth. Various key
market players are playing a vital role in the development of drugs with the
help of NGS technology which is expected to augment the market growth over the
forecast years.
However, absence of skilled
professionals, and ethical and legal limitation associated with next genome
sequencing are expected to restrict the market growth during the forecast
period.
Browse over XX market
data Figures spread through 70 Pages and an in-depth TOC on "UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET"
The United Kingdom next generation
sequencing market is segmented into product, technology,
application, end user, regional distribution, and competitive
landscape.
Based on product, the
market is divided into consumables, platforms, services. Consumables segment account for a large
share in the market in the forecast period, 2023-2027. Consumables offers short
durability, thereby there is a high replacement rate that escalates the demand
for consumables. Also, consumables are ordered in abundant quantity from
numerous producers owing to a cost-effective way for researchers as well as
scientists that improves the market value. Major industry manufacturers are
taking several efforts in developing innovative consumables that will help
researchers gain accurate results, accelerating the industry expansion.
Based on technology, the market is
segmented into sequencing by synthesis, ion semiconductor sequencing,
sequencing by ligation, single molecule real time sequencing, others. Sequencing
by synthesis is expected to dominate during the forecast years, 2023-2027. The high
accuracy of SBS technology in DNA sequencing, greatest yield of error free
throughput, and rising incorporation of this technology in NGS instrumentation
is driving the segmental growth.
Based on application, the
market is divided into biomarkers & cancer, diagnostics, reproductive
health, personalized medicine, agriculture & animal research, others. Biomarkers and cancer segment
is projected to hold the greatest share during the upcoming years, 2023-2027.
It is due to the rise in prevalence of cancer and advancement in technology in
next generation sequencing which propels the segmental growth.
Based on end user, the market is
segmented into academic & clinical research centers, pharmaceutical &
biotechnology companies, hospitals & clinics, others. Academic &
clinical research centers is projected to augment the market growth during the
forecast years, 2023-2027. The growing application-based utilization in these
institutes and rising oncology research activities are fueling the growth of
this segment.
Leading market players operating in the
United Kingdom next generation sequencing market are:
- Thermo Fischer Scientific, Inc.
- Illumina Cambridge Limited
- PerkinElmer (UK) Limited
- Agilent Technologies UK Limited
- Qiagen Manchester Limited
- Oxford Nanopore Technologies Limited
- Roche Diagnostics Limited
DOWNLOAD FREE SAMPLE REPORT
Customers can also
request for 10% free customization on this report.
“The growing prevalence of
several medical diseases, including cancer, coupled with the numerous
technological advancements in the field of medical sciences, is primarily
supporting the growth of the next generation sequencing market. The expanding
adoption of liquid biopsies in cancer diagnostics, has further escalated the
utilization of NGS technologies which is propelling the market growth. These
technologies use cell-free circulating tumor DNA (ctDNA) as a non-invasive
cancer biomarker for real-time cancer monitoring and detection. In addition to
this, the rising adoption of genome mapping programs to predict the development
of several disorders is also providing an impetus to the market growth. Genetic
maps are widely utilized for guiding scientists to analyse the genes that are
responsible for increasing the prevalence of diabetes, heart diseases, asthma,
cancer and psychiatric conditions. Furthermore, continuous technological
advancements and integration with the cloud-computing systems for enhanced data
management, are offering lucrative opportunities to the market players. The
lowering costs of NGS systems and extensive research and development (R&D)
activities in the area of sequencing chemistry, molecular biology and technical
engineering, are expected to fuel the growth of United Kingdom next-generation
sequencing market till 2027” said Mr. Karan Chechi, Research Director
with TechSci Research, a research based global management consulting firm”.
“United Kingdom Next
Generation Sequencing Market By Product (Consumables, Platforms, Services), By
Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing
by Ligation, Single Molecule Real Time Sequencing, Others), By Application
(Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized
Medicine, Agriculture & Animal Research, Others), By End User (Academic
& Clinical Research Centers, Pharmaceutical & Biotechnology Companies,
Hospitals & Clinics, Others), By Region, Competition Forecast &
Opportunities, 2027 has
analyzed the future growth potential of United Kingdom next generation
sequencing market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and assist
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with significant drivers,
challenges, and opportunities in United Kingdom next generation sequencing
market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com